示警性预防护理对重症肺炎患者风险系数及临床结局的影响

doi:10.3760/cma.j.issn.1007-1245.2023.17.028

摘要/Abstract

摘要：

目的　探究示警性预防护理在重症肺炎患者中的临床效果。方法　本文为前瞻性研究。选取2021年4月至2022年7月无锡市第二人民医院重症医学科收治的60例重症肺炎患者作为研究对象，根据随机数字表法将其分为两组，各30例。参照组男16例、女14例，年龄（66.42±3.51）岁，实施常规护理措施；干预组男18例、女12例，年龄（66.33±3.42）岁，实施示警性预防护理措施。对比两组入院1 d、出院前1 d风险系数、呼吸肺功能及并发症等发生情况。采用t检验、χ²检验。结果　出院前1 d，干预组英国胸科协会改良肺炎评分（CURB-65）［（2.03±0.12）分］、肺炎严重指数（PSI）［（84.43±5.33）分］均低于参照组［（2.19±0.21）分、（88.21±5.32）分］，差异均有统计学意义（均P<0.05）。出院前1 d，干预组1秒用力呼气容积（FEV1）［（84.24±1.42）%］、动脉血氧分压（PaO₂）［（86.21±1.33）mmHg（1 mmHg=0.133 kPa）］、最大通气量（MVV）［（85.35±1.42）%］、用力肺活量（FVC）［（85.23±1.42）%］均高于参照组［（83.49±1.33）%、（85.32±1.42）mmHg、（84.33±1.44）%、（84.41±1.41）%］，差异均有统计学意义（均P<0.05）。干预组并发症发生率为3.33%（1/30），低于参照组23.33%（7/30），差异有统计学意义（χ²=5.192，P=0.023）。结论　对收治的重症肺炎患者实施示警性预防护理措施，有助于降低患者风险系数水平，改善呼吸肺功能状态，减少并发症发生率。

关键词:

重症肺炎, 示警性, 预防护理, 风险系数, 呼吸肺功能, 并发症

Abstract:

Objective　To explore the clinical effect of warning preventive nursing in patients with severe pneumonia. Methods　It was a prospective study. Sixty patients with severe pneumonia admitted to Department of Intensive Care Medicine, Wuxi Second People's Hospital from April 2021 to July 2022 were selected as the research objects, and were divided into a control group and an intervention group according to the random number table method with 30 cases in each group. In the control group, 16 males and 14 females, aged (66.42±3.51) years, were given routine nursing measures; in the intervention group, 18 males and 12 females, aged (66.33±3.42) years, were given warning preventive nursing measures. The risk coefficients and respiratory function 1 day after admission and 1 day before discharge and complications were compared between the two groups. t test and χ² test were used. Results　One day before discharge, the CURB-65 (confusion, uremia, respiratory, BP, age 65 years) score [(2.03±0.12) points] and pneumonia severity index (PSI) [(84.43±5.33) points] in the intervention group were lower than those in the control group [(2.19±0.21) points and (88.21±5.32) points], with statistically significant differences (both P<0.05). One day before discharge, the forced expiratory volume in one second (FEV1) [(84.24±1.42)%], partial oxygen pressure (PaO₂) [(86.21±1.33) mmHg (1 mmHg=0.133 kPa)], maximum ventilatory volume (MVV) [(85.35±1.42)%], and forced vital capacity (FVC) [(85.23±1.42)%] in the intervention group were higher than those in the control group [(83.49±1.33)%, (85.32±1.42) mmHg, (84.33±1.44)%, and (84.41±1.41)%], with statistically significant differences (all P<0.05). The complication rate in the intervention group was 3.33% (1/30), which was lower than that in the reference group [23.33% (7/30)], with a statistically significant difference (χ²=5.192, P=0.023). Conclusion　The implementation of warning preventive nursing measures for severe pneumonia patients is helpful to reducing the level of risk coefficient, improve the status of respiratory lung function, and reduce the incidence of complications.

Key words:

Severe pneumonia, Alertness, Preventive nursing, Risk coefficient, Respiratory lung function, Complications

潘海萍何平.

示警性预防护理对重症肺炎患者风险系数及临床结局的影响 [J]. 国际医药卫生导报, 2023, 29(17): 2494-2498.

Pan Haiping, He Ping.

Effect of warning preventive nursing on risk coefficient and clinical outcomes in patients with severe pneumonia [J]. International Medicine and Health Guidance News, 2023, 29(17): 2494-2498.

参考文献

[1] 王僚瑶,李宣霖,张康,等. 中西医结合治疗重症肺炎疗效及安全性的meta分析[J]. 辽宁中医杂志,2019,46(5):911-916.DOI:10.13192/j.issn.1000-1719.2019.05.005.
[2] 冯开俊,张泓. 血小板相关参数联合肺炎严重指数评分对重症肺炎患者病死率的预测作用[J]. 中国急救医学,2019,39(8):739-743.DOI:10.3969/j.issn.1002-1949.2019. 08.006.
[3] 郑丽,牟春英,黎巧玲.1例重症肺炎患者体外膜肺氧合联合连续性肾脏替代及机械通气治疗的康复护理[J].现代临床护理,2021,20(9):81-85.DOI:10.3969/j.issn.1671-8283. 2021.9.015.
[4] 王妍,郭晓芳,陈显成,等. 多粘菌素B为基础联合治疗泛耐药菌重症肺炎的临床观察[J]. 中国感染控制杂志,2020,19(11):976-980.DOI:10.12138/j.issn.1671-9638. 20205855.
[5] 张志辉,刘学松,陈思蓓,等. 人巨细胞病毒再活化在非免疫抑制机械通气重症肺炎患者中的发生及预后分析[J]. 中华危重病急救医学,2021,33(3):286-292.DOI:10.3760/cma.j.cn121430-20201015-00671.
[6] 刘晓玲,秦庆员. 痰热清注射液联合哌拉西林舒巴坦治疗老年重症肺炎的临床疗效及对血清炎症因子的影响[J]. 国际医药卫生导报,2019,25(4):603-606.DOI:10.3760/cma.j.issn.1007-1245.2019.04.032.
[7] 中华医学会,中华医学会杂志社,中华医学会全科医学分会,等. 成人社区获得性肺炎基层诊疗指南(2018年)[J]. 中华全科医师杂志,2019,18(2):117-126.DOI:10.3760/cma.j.issn.1671-7368.2019.02.005.
[8] Ludvigsson JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults[J]. Acta Paediatr,2020,109(6):1088-1095.DOI:10.1111/apa.15270.
[9] 何芳,刘美成. 盐酸氨溴索联合纤维支气管镜吸痰治疗老年重症肺炎的疗效及对患者APACHEⅢ评分及氧合指数的影响[J]. 河北医学,2019,25(1):78-82.DOI:10.3969/j.issn.1006-6233.2019.01.020.
[10] 刘连杰,杜然,王心妹,等. 经纤维支气管镜灌洗联合乙酰半胱氨酸治疗重症肺炎患儿的效果及对细胞间黏附分子1和肾上腺髓质素水平的影响[J]. 中国医药,2021,16(6):845-848.DOI:10.3760/j.issn.1673-4777.2021.06.011.
[11] 黄艳,邵景天,黄丽娴,等.纤维支气管镜灌洗治疗重症肺炎的疗效观察[J].现代医院,2021,21(12):1956-1958,1962.DOI:10.3969/j.issn.1671-332X.2021.12.045.
[12] 李虎年,何婷,刘杰,等.巨噬细胞移动抑制因子基因沉默骨髓间充质干细胞移植对重症肺炎大鼠的影响研究[J].中国临床药理学杂志,2020,36(5):507-510.DOI:10.13699/j.cnki.1001-6821.2020.05.008.
[13] 孙睿甜. 胸腺五肽治疗重症肺炎合并脓毒血症的临床疗效及对血清因子的影响[J]. 现代药物与临床,2021,36(5):1013-1017.DOI:10.7501/j.issn.1674-5515.2021.05.031.
[14] 王晓华,何秋敏. 针对性护理对老年重症肺炎并呼吸机相关性肺炎患者康复进程及护理满意度的影响[J]. 国际护理学杂志,2019,38(2):238-242.DOI:10.3760/cma.j.issn.1673- 4351.2019.02.031.
[15] 刘翔腾,王桂兰,黄娟,等. 快速现场评价技术在指导儿童重症肺炎支气管肺泡灌洗后续诊疗价值的初步评价[J]. 临床肺科杂志,2021,26(11):1672-1676.DOI:10.3969/j.issn.1009-6663.2021.11.013.
[16] 陈春燕,马小容,杨巍. MEWS评分联合外周血cf-DNA/NETs水平对重症肺炎病情及预后的评估价值[J]. 临床和实验医学杂志,2021,20(18):1970-1973.DOI:10.3969/j.issn.1671-4695.2021.18.018.
[17] 张添威,郭微微,张蓉映,等. 动态监测血清CRP对指导重症肺炎患者临床用药的意义及联合IL-8、Th1对预后预警的价值[J]. 广东医学,2021,42(3):283-287.DOI:10.13820/j.cnki.gdyx.20192642.
[18] 潘海萍,何平. ICU早期肺康复方案对重症肺部感染的护理效果观察[J]. 国际医药卫生导报,2021,27(2):283-286.DOI:10.3760/cma.j.issn.1007-1245.2021.02.034.
[19] 朱秀琪. 酚妥拉明多巴胺及多巴酚丁胺联合经鼻持续气道正压通气治疗小儿重症肺炎合并呼吸衰竭的疗效及对炎症细胞因子水平的影响[J]. 中国妇幼保健,2021,36(12):2773-2776.DOI:10.19829/j.zgfybj.issn.1001-4411.2021. 12.029.
[20] 郭茹,刘利霞,廖晓阳. 皮质类固醇激素辅助治疗重症肺炎的系统评价/meta分析方法学与报告质量评价[J]. 华西医学,2019,34(1):74-81.DOI:10.7507/1002-0179. 201901055.
[21] 纪莉,钱东华.早期降钙素原和氧合指数水平在老年重症肺炎患者预后评估中的价值[J].中国老年学杂志,2018,38(23):5715-5718.
[22] 黎小梅,夏宏,郑应莲,等. 外周血纤维蛋白降解产物、单核细胞/淋巴细胞比值、中性粒细胞/淋巴细胞比值对重症肺炎患儿预后的评估价值[J]. 儿科药学杂志,2021,27(2):5-9.DOI:10.13407/j.cnki.jpp.1672-108X.2021.02.002.
[23] 张慧芳,张雪,沙玉霞,等. 血清及支气管肺泡灌洗液中sTREM-1水平、APACHE Ⅱ评分及SOFA评分对重症肺炎患儿病情及预后评价[J]. 中国当代儿科杂志,2020,22(6):626-631.DOI:10.7499/j.issn.1008-8830.1912134.
[24] 冯敏,潘岁月. 基于气道分级管理策略的胸部物理治疗在老年重症肺炎机械通气患者中的应用[J]. 护士进修杂志,2019,34(19):1810-1813.DOI:10.16821/j.cnki.hsjx.2019. 19.021.
[25] 徐梦,卢瑞萍,朱丽,等. 外周血单核细胞中NLRP3 mRNA、Caspase-1 mRNA、IL-1β及IL-18表达水平与重症肺炎患者病情严重程度及预后的相关性分析[J]. 标记免疫分析与临床,2021,28(7):1110-1114,1120.DOI:10.11748/bjmy.issn.1006-1703.2021.07.007.
[26] 贾民勇,牛建伟,王少芳,等. 国产利奈唑胺治疗革兰氏阳性球菌感染重症肺炎患者疗效评价及其影响因素分析[J]. 中国现代应用药学,2019,36(3):343-348.DOI:10.13748/j.cnki.issn1007-7693.2019.03.018.
[27] 李玉华,马兵,胡莹莹,等. 重症肺炎患儿血清颗粒蛋白前体、血清淀粉样蛋白A水平变化及其与病情和预后的关系[J]. 山东医药,2021,61(16):16-19.DOI:10.3969/j.issn.1002- 266X.2021.16.004.
[28] 厉兰,彭贻界,王安琪,等. 支气管镜肺泡灌洗联合抗生素对小儿重症肺炎的疗效及对痰细菌清除率等指标的影响[J]. 中国微生态学杂志,2021,33(7):818-820,824.DOI:10.13381/j.cnki.cjm.202107015.
[29] 石丹英,张红英. 加温湿化高流量鼻导管氧疗与nCPAP在小儿重症肺炎呼吸衰竭辅助治疗中的应用对比观察[J]. 山东医药,2021,61(18):69-71.DOI:10.3969/j.issn.1002- 266X.2021.18.017.
[30] 则学英,安春霞,刘磊. 利奈唑胺联合美罗培南治疗重症肺炎疗效观察及对患者肺泡灌洗液中miR-127-5p、miR-3686表达的影响[J]. 中国药师,2021,24(5):884-888.DOI:10.3969/j.issn.1008-049X.2021.05.018.
[31] 谢诚,樊映红,艾涛,等. 丙种球蛋白与阿奇霉素治疗小儿重症肺炎支原体肺炎的效果及对CRP T淋巴细胞亚群免疫球蛋白水平的影响[J]. 河北医学,2020,26(9):1446-1450.DOI:10.3969/j.issn.1006-6233.2020.09.010.
[32] 张晓曼,冯雷,童金莲,等. 免疫增强型与普通肠内营养制剂对老年重症肺炎营养状态、肠黏膜屏障功能及T细胞亚群的影响[J]. 现代生物医学进展,2021,21(12):2245-2248.DOI:10.13241/j.cnki.pmb.2021.12.010.
[33] Bartoš H, Džupová O. Severe community-acquired pneumonia in intensive care[J].Epidemiol Mikrobiol Imunol,2020,69(4):159-163.